{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:13:09Z","timestamp":1793113989248,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173398"],"award-info":[{"award-number":["82173398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2018SK2087"],"award-info":[{"award-number":["2018SK2087"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunotherapy is a vital treatment for patients with cutaneous melanoma (CM), but effective predictors to guide clinical immunotherapy are lacking. Cuproptosis is a newly discovered mode of cell death related to tumorigenesis. Exploring the relationship between the mode of cuproptosis and the effect of immunotherapy on CM could better guide clinical management. We clustered all patients with CM in the Cancer Genome Atlas (TCGA) database based on cuproptosis-related genes (CRGs). Prognosis, immunotherapeutic effect, tumor microenvironment score, expression of CD274, CTLA4, and PDCD1, and abundance of CD8\u2009+\u2009T infiltration in group A were higher than in group B. Using a combination of LASSO and COX regression analysis, we identified 10 molecules significant to prognosis from differentially expressed genes between the two groups and constructed a cuproptosis-related scoring system (CRSS). Compared with the American Joint Committee on Cancer (AJCC) staging system, CRSS more accurately stratified CM patient risk and guided immunotherapy. CRSS successfully stratified risk and predicted the effect of immunotherapy in 869 patients with eight CM immunotherapy datasets and multiple other tumor immunotherapy cohorts. The nomogram model, which combined AJCC stage and CRSS, greatly improved the ability and accuracy of prognosis prediction. In general, our cuproptosis-related scoring system and nomogram model accurately stratified risk in CM patients and effectively predicted prognosis and the effect of immunotherapy in CM patients.<\/jats:p>","DOI":"10.1186\/s12967-023-03891-4","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T05:04:04Z","timestamp":1675055044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Da","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0135-8579","authenticated-orcid":false,"given":"Rui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"issue":"1","key":"3891_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"48","key":"3891_CR2","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1038\/onc.2017.292","volume":"36","author":"J Leclerc","year":"2017","unstructured":"Leclerc J, Ballotti R, Bertolotto C. Pathways from senescence to melanoma: focus on MITF sumoylation. Oncogene. 2017;36(48):6659\u201367.","journal-title":"Oncogene"},{"issue":"2","key":"3891_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22(2):102\u201313.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"3891_CR4","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1039\/d0mt00156b","volume":"12","author":"CI Davis","year":"2020","unstructured":"Davis CI, Gu X, Kiefer RM, Ralle M, Gade TP, Brady DC. Altered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation. Metallomics. 2020;12(12):1995\u20132008.","journal-title":"Metallomics"},{"issue":"2","key":"3891_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1039\/C6MT00202A","volume":"9","author":"S Blockhuys","year":"2017","unstructured":"Blockhuys S, Celauro E, Hildesj\u00f6 C, Feizi A, St\u00e5l O, Fierro-Gonz\u00e1lez JC, et al. Defining the human copper proteome and analysis of its expression variation in cancers. Metallomics. 2017;9(2):112\u201323.","journal-title":"Metallomics"},{"issue":"6586","key":"3891_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361.","journal-title":"Science"},{"issue":"11","key":"3891_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41423-022-00925-7","volume":"19","author":"X Shan","year":"2022","unstructured":"Shan X, Hu P, Ni L, Shen L, Zhang Y, Ji Z, et al. Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis. Cell Mol Immunol. 2022;19(11):1263\u201378.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"3891_CR8","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1021\/acs.jmedchem.1c01248","volume":"65","author":"M Bian","year":"2022","unstructured":"Bian M, Fan R, Yang Z, Chen Y, Xu Z, Lu Y, et al. Pt(II)-NHC complex induces ROS-ERS-related DAMP balance to harness immunogenic cell death in hepatocellular carcinoma. J Med Chem. 2022;65(3):1848\u201366.","journal-title":"J Med Chem"},{"issue":"9","key":"3891_CR9","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1038\/s41423-020-0456-1","volume":"18","author":"C Fang","year":"2021","unstructured":"Fang C, Mo F, Liu L, Du J, Luo M, Men K, et al. Oxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine. Cell Mol Immunol. 2021;18(9):2211\u201323.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"3891_CR10","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1111\/cas.15499","volume":"113","author":"R Mao","year":"2022","unstructured":"Mao R, Ren Z, Yang F, Yang P, Zhang T. Clinical significance and immune landscape of KIR2DL4 and the senescence-based signature in cutaneous melanoma. Cancer Sci. 2022;113(11):3947\u201359.","journal-title":"Cancer Sci"},{"issue":"6","key":"3891_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"key":"3891_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2022.08.004","author":"Z Chen","year":"2022","unstructured":"Chen Z, Luo Z, Zhang D, Li H, Liu X, Zhu K, et al. TIGER: a web portal of tumor immunotherapy gene expression resource. Geno Prot Bioinform. 2022. https:\/\/doi.org\/10.1016\/j.gpb.2022.08.004.","journal-title":"Geno Prot Bioinform"},{"issue":"5","key":"3891_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41591-018-0012-z","volume":"24","author":"J Shen","year":"2018","unstructured":"Shen J, Ju Z, Zhao W, Wang L, Peng Y, Ge Z, et al. ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade. Nat Med. 2018;24(5):556\u201362.","journal-title":"Nat Med"},{"key":"3891_CR14","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214-20.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"3891_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"12","key":"3891_CR16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"key":"3891_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-1-4939-6613-4_19","volume":"1526","author":"GJ McLachlan","year":"2017","unstructured":"McLachlan GJ, Bean RW, Ng SK. Clustering. Methods Mol Biol. 2017;1526:345\u201362.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"3891_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"1","key":"3891_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu J, Li K, Zhang W, Wan C, Zhang J, Jiang P, et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 2020;12(1):21.","journal-title":"Genome Med"},{"key":"3891_CR20","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"4","key":"3891_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s40610-017-0073-7","volume":"3","author":"F Runa","year":"2017","unstructured":"Runa F, Hamalian S, Meade K, Shisgal P, Gray PC, Kelber JA. Tumor microenvironment heterogeneity: challenges and opportunities. Curr Mol Biol Rep. 2017;3(4):218\u201329.","journal-title":"Curr Mol Biol Rep"},{"issue":"5","key":"3891_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"3891_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"issue":"1","key":"3891_CR24","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER20 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(1):W509-509W514.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"3891_CR25","doi-asserted-by":"publisher","first-page":"20778","DOI":"10.18632\/aging.104014","volume":"12","author":"R Mao","year":"2020","unstructured":"Mao R, Chen Y, Xiong L, Liu Y, Zhang T. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Aging. 2020;12(20):20778\u2013800.","journal-title":"Aging"},{"key":"3891_CR26","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3389\/fonc.2020.01673","volume":"10","author":"R Mao","year":"2020","unstructured":"Mao R, Hu S, Zhang Y, Du F, Zhang Y, Liu Y, et al. Prognostic nomogram for childhood acute lymphoblastic leukemia: a comprehensive analysis of 673 patients. Front Oncol. 2020;10:1673.","journal-title":"Front Oncol"},{"key":"3891_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6947-8-53","volume":"8","author":"AJ Vickers","year":"2008","unstructured":"Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"18","key":"3891_CR28","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157\u201364.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3891_CR29","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/sim.4780090710","volume":"9","author":"Y Hochberg","year":"1990","unstructured":"Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9(7):811\u20138.","journal-title":"Stat Med"},{"issue":"15","key":"3891_CR30","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1158\/1078-0432.CCR-20-4314","volume":"27","author":"CW Abbott","year":"2021","unstructured":"Abbott CW, Boyle SM, Pyke RM, McDaniel LD, Levy E, Navarro F, et al. Prediction of immunotherapy response in melanoma through combined modeling of neoantigen burden and immune-related resistance mechanisms. Clin Cancer Res. 2021;27(15):4265\u201376.","journal-title":"Clin Cancer Res"},{"key":"3891_CR31","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0983","author":"FS Hodi","year":"2021","unstructured":"Hodi FS, Wolchok JD, Schadendorf D, Larkin J, Long GV, Qian X, et al. TMB and Inflammatory gene expression associated with clinical outcomes following immunotherapy in advanced melanoma. Cancer Immunol Res. 2021. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0983.","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"3891_CR32","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1172\/JCI44849","volume":"121","author":"KT Byrne","year":"2011","unstructured":"Byrne KT, C\u00f4t\u00e9 AL, Zhang P, Steinberg SM, Guo Y, Allie R, et al. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma. J Clin Invest. 2011;121(5):1797\u2013809.","journal-title":"J Clin Invest"},{"issue":"1","key":"3891_CR33","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1038\/s41467-021-25559-7","volume":"12","author":"SH Kim","year":"2021","unstructured":"Kim SH, Cho E, Kim YI, Han C, Choi BK, Kwon BS. Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18R\u03b1hi CD8+ T cells. Nat Commun. 2021;12(1):5314.","journal-title":"Nat Commun"},{"issue":"5","key":"3891_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503\u201310.","journal-title":"Nat Immunol"},{"issue":"9244","key":"3891_CR35","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","volume":"356","author":"K Imai","year":"2000","unstructured":"Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet. 2000;356(9244):1795\u20139.","journal-title":"Lancet"},{"issue":"W1","key":"3891_CR36","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li C, Tang Z, Zhang W, Ye Z, Liu F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242-242W246.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3891_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI122955","volume":"129","author":"J Rayes","year":"2019","unstructured":"Rayes J, Watson SP, Nieswandt B. Functional significance of the platelet immune receptors GPVI and CLEC-2. J Clin Invest. 2019;129(1):12\u201323.","journal-title":"J Clin Invest"},{"key":"3891_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-6-1","volume":"6","author":"JD Mellor","year":"2013","unstructured":"Mellor JD, Brown MP, Irving HR, Zalcberg JR, Dobrovic A. A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer. J Hematol Oncol. 2013;6:1.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"3891_CR39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/gutjnl-2014-307234","volume":"64","author":"R Geva","year":"2015","unstructured":"Geva R, Vecchione L, Kalogeras KT, Jensen BV, Lenz HJ, Yoshino T, et al. FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study. Gut. 2015;64(6):921\u20138.","journal-title":"Gut"},{"issue":"1","key":"3891_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1182\/blood-2004-02-0651","volume":"105","author":"TS Lin","year":"2005","unstructured":"Lin TS, Flinn IW, Modali R, Lehman TA, Webb J, Waymer S, et al. FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia. Blood. 2005;105(1):289\u201391.","journal-title":"Blood"},{"issue":"3","key":"3891_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jamaoncol.2016.4884","volume":"3","author":"PG Gavin","year":"2017","unstructured":"Gavin PG, Song N, Kim SR, Lipchik C, Johnson NL, Bandos H, et al. Association of Polymorphisms in FCGR2A and FCGR3A with degree of trastuzumab benefit in the adjuvant treatment of ERBB2\/HER2-positive breast cancer: analysis of the NSABP B-31 trial. JAMA Oncol. 2017;3(3):335\u201341.","journal-title":"JAMA Oncol"},{"issue":"4","key":"3891_CR42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/jth.15647","volume":"20","author":"J Lagrange","year":"2022","unstructured":"Lagrange J, Lecompte T, Knopp T, Lacolley P, Regnault V. Alpha-2-macroglobulin in hemostasis and thrombosis: An underestimated old double-edged sword. J Thromb Haemost. 2022;20(4):806\u201315.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3891_CR43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1158\/0008-5472.CAN-09-1462","volume":"70","author":"I Lindner","year":"2010","unstructured":"Lindner I, Hemdan NY, Buchold M, Huse K, Bigl M, Oerlecke I, et al. Alpha2-macroglobulin inhibits the malignant properties of astrocytoma cells by impeding beta-catenin signaling. Cancer Res. 2010;70(1):277\u201387.","journal-title":"Cancer Res"},{"key":"3891_CR44","doi-asserted-by":"publisher","first-page":"15987","DOI":"10.1038\/ncomms15987","volume":"8","author":"PJ Cook","year":"2017","unstructured":"Cook PJ, Thomas R, Kannan R, de Leon ES, Drilon A, Rosenblum MK, et al. Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target. Nat Commun. 2017;8:15987.","journal-title":"Nat Commun"},{"issue":"2","key":"3891_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-1119(00)00362-0","volume":"256","author":"SC Gary","year":"2000","unstructured":"Gary SC, Zerillo CA, Chiang VL, Gaw JU, Gray G, Hockfield S. cDNA cloning, chromosomal localization, and expression analysis of human BEHAB\/brevican, a brain specific proteoglycan regulated during cortical development and in glioma. Gene. 2000;256(2):139\u201347.","journal-title":"Gene"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03891-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03891-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03891-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T08:19:22Z","timestamp":1675239562000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03891-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3891"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03891-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}